Archives
-
2-NBDG and the Next Era of Metabolic Translation
2026-10-06
A translational framework connecting fluorescent glucose uptake measurement with HNF4A-AS1, lipid remodeling, ferroptosis, and sorafenib resistance in hepatocellular carcinoma—while clarifying what 2-NBDG can and cannot prove.
-
Oleic Acid: Evidence, Scope and Limitations
2026-10-06
A five-question, source-grounded overview of Oleic Acid and C18:1(9Z), explaining lipid-signaling principles, what a recent hepatic ischemia-reperfusion study actually tested, how strong the evidence is, and where interpretation must stop.
-
RapaLink-1: mTOR Inhibition in Research Context
2026-10-05
A source-grounded overview of RapaLink-1, its proposed bivalent mTOR mechanism, the evidence for pharmacological mTOR inhibition in embryonic dormancy, reported glioma findings, and the boundaries of current evidence.
-
Nonivamide and TRPV1: Evidence, Uses, and Limits
2026-10-05
Nonivamide is a capsaicin analog commonly studied as a TRPV1 agonist. Available information supports a plausible role in sensory-neuron and cancer research, but the strongest supplied evidence concerns capsaicin rather than nonivamide itself. This overview separates direct findings from mechanistic interpretation and highlights translational limits.
-
MMP-Responsive Hydrogel for Fibrous Dysplasia
2026-10-04
Xing and colleagues developed an injectable hyaluronic acid-based hydrogel containing triglycerol monostearate nanoparticles for lesion-responsive delivery of a RANKL inhibitor in fibrous dysplasia. Their preclinical findings suggest that matrix metalloproteinase activity can provide a disease-associated signal for local drug release, although the evidence remains limited to in vitro studies and a mouse model.
-
Berbamine Hydrochloride and Ferroptosis Resistance
2026-10-03
A translational perspective on Berbamine hydrochloride, NF-κB pathway hypotheses, and the METTL16-SENP3-LTF axis described in hepatocellular carcinoma.
-
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody
2026-10-02
Turn goat-primary immunofluorescence into a reproducible workflow for mapping FXR-associated replication-organelle organization. This Alexa Fluor 488 conjugated secondary antibody combines affinity-purified anti-goat specificity with flexible use in imaging, Western blotting, flow cytometry, immunohistochemistry, and ELISA.
-
qPCR Master Mix for RNA Delivery Validation
2026-10-01
Discover how a qPCR master mix can support rigorous validation of emerging RNA delivery platforms. This guide connects HotStart™ Universal Blue 2X Green qPCR Master Mix (with UDG) to assay design, contamination control, and the practical interpretation of nucleic acid delivery experiments.
-
Novobiocin: From Target Validation to Assay Design
2026-10-01
Novobiocin is an aminocoumarin antibiotic with applications extending from bacterial DNA gyrase studies to parasite selectivity testing. This article develops an evidence-centered framework for choosing orthogonal assays, interpreting concentration data, and separating promising target biology from translational readiness.
-
LRPPRC–Dasatinib Synergy in Tumor OXPHOS
2026-09-30
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central mechanistic finding is that the two interventions disrupt complementary OXPHOS gene pools: dasatinib suppresses nuclear-encoded programs, whereas LRPPRC inhibition preferentially impairs mitochondrial genome-encoded transcripts.
-
Safer pDNA Delivery with Anti-Inflammatory Lipids
2026-09-30
The reference study shows that plasmid DNA lipid nanoparticles can trigger severe acute inflammation through the cGAS–STING pathway, limiting their use despite DNA’s potential for durable, promoter-controlled expression. Loading nitro-oleic acid into the particles reduced inflammatory toxicity and enabled substantially longer transgene expression, while formulation screening further improved expression in vitro.
-
2X Taq PCR Master Mix for Stress-Gene Validation
2026-09-29
Learn how 2X Taq PCR Master Mix supports defensible genotyping, TA cloning, and endpoint validation in plant stress research. This article translates cassava A20/AN1 findings into practical assay and workflow decisions.
-
Arachidonic Acid: Designing Better Lipid Assays
2026-09-29
Arachidonic Acid is more than an inflammatory stimulus: it is a time-dependent, compartment-sensitive substrate for lipid signaling. This guide translates recent humoral-immunity findings into practical decisions for eicosanoid, enzyme-inhibition, and immune-cell assay design.
-
6-OHDA Models: From Lesion to Translation
2026-09-28
6-OHDA hydrochloride remains a powerful tool for creating mechanistically interpretable catecholaminergic lesion models. This thought-leadership guide explains how to strengthen experimental validation, position the model against competing paradigms, and translate lesion biology into more reliable therapeutic and delivery decisions.
-
Worenine Modulates PBK/SRC Signaling in Lung Fibrosis
2026-09-28
The study combines network pharmacology, molecular docking, and cell and animal experiments to investigate how worenine may reduce pulmonary fibrosis. Its findings connect PBK/SRC-associated signaling with changes in TGF-β1/Smad, ERK, and NF-κB pathways, while providing preclinical evidence—not proof of clinical efficacy—for further study.